• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » NIH Council of Councils members named

NIH Council of Councils members named

June 22, 2015
CenterWatch Staff

The National Institutes of Health has announced the appointment of eight individuals to the NIH Council of Councils. The council was established to advise the NIH director on policies and activities of the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), including making recommendations on research that represents important areas of emerging scientific opportunities, rising public health challenges, or knowledge gaps that deserve special emphasis or would otherwise benefit from strategic planning and coordination.

The council is composed of 27 members nominated by the NIH Institutes and Centers (ICs) and offices within the Office of the Director (OD). Council members bring knowledge of IC’s and OD office missions and operations, not as official representatives, but to provide advice beyond the research agenda of any individual IC. 

The following members will serve terms on the council through Oct. 31, 2017:

  • Sharon Anderson, M.D., Oregon Health & Science University, Portland
  • Mary Lindsey Carnes, M.D., M.S., University of Wisconsin-Madison
  • Hakon Heimer, M.S., Schizophrenia Research Forum, Brain and Behavior Research Foundation, Providence, R.I.
  • Terry L. Jernigan, Ph.D., University of California, San Diego
  • Vivian S. Lee, M.D., Ph.D., M.B.A., University of Utah, Salt Lake City
  • Kimberly K. Leslie, M.D., University of Iowa Hospitals and Clinics, Iowa City
  • Guillermina Lozano, Ph.D., the University of Texas MD Anderson Cancer Center, Houston
  • Keith A. Reimann, D.V.M., University of Massachusetts Medical School, Boston

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing